Olschewski, V.; Witte, H.M.; Bernard, V.; Steinestel, K.; Peter, W.; Merz, H.; Rieken, J.; Biersack, H.; von Bubnoff, N.; Feller, A.C.;
et al. Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. Cancers 2021, 13, 887.
https://doi.org/10.3390/cancers13040887
AMA Style
Olschewski V, Witte HM, Bernard V, Steinestel K, Peter W, Merz H, Rieken J, Biersack H, von Bubnoff N, Feller AC,
et al. Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. Cancers. 2021; 13(4):887.
https://doi.org/10.3390/cancers13040887
Chicago/Turabian Style
Olschewski, Vito, Hanno M. Witte, Veronica Bernard, Konrad Steinestel, Wolfgang Peter, Hartmut Merz, Johannes Rieken, Harald Biersack, Nikolas von Bubnoff, Alfred C. Feller,
and et al. 2021. "Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements" Cancers 13, no. 4: 887.
https://doi.org/10.3390/cancers13040887
APA Style
Olschewski, V., Witte, H. M., Bernard, V., Steinestel, K., Peter, W., Merz, H., Rieken, J., Biersack, H., von Bubnoff, N., Feller, A. C., & Gebauer, N.
(2021). Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. Cancers, 13(4), 887.
https://doi.org/10.3390/cancers13040887
